Bouchey Financial Group Ltd Takes Position in Axon Enterprise, Inc. (NASDAQ:AXON)

Bouchey Financial Group Ltd purchased a new stake in shares of Axon Enterprise, Inc. (NASDAQ:AXONFree Report) during the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm purchased 374 shares of the biotechnology company’s stock, valued at approximately $222,000.

Other hedge funds and other institutional investors have also modified their holdings of the company. Public Sector Pension Investment Board grew its stake in Axon Enterprise by 19.2% in the 3rd quarter. Public Sector Pension Investment Board now owns 3,104 shares of the biotechnology company’s stock valued at $1,240,000 after buying an additional 500 shares during the last quarter. CIBC Asset Management Inc grew its stake in Axon Enterprise by 9.2% in the 3rd quarter. CIBC Asset Management Inc now owns 10,578 shares of the biotechnology company’s stock valued at $4,227,000 after buying an additional 895 shares during the last quarter. Axxcess Wealth Management LLC acquired a new position in Axon Enterprise in the 3rd quarter valued at $814,000. Soros Capital Management LLC acquired a new position in Axon Enterprise in the 3rd quarter valued at $630,000. Finally, Friedenthal Financial grew its stake in Axon Enterprise by 961.7% in the 4th quarter. Friedenthal Financial now owns 1,359 shares of the biotechnology company’s stock valued at $808,000 after buying an additional 1,231 shares during the last quarter. Institutional investors own 79.08% of the company’s stock.

Insider Transactions at Axon Enterprise

In other news, President Joshua Isner sold 1,291 shares of the firm’s stock in a transaction dated Tuesday, December 17th. The shares were sold at an average price of $642.43, for a total transaction of $829,377.13. Following the completion of the transaction, the president now directly owns 181,892 shares of the company’s stock, valued at approximately $116,852,877.56. This trade represents a 0.70 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, Director Caitlin Elizabeth Kalinowski sold 450 shares of Axon Enterprise stock in a transaction dated Thursday, January 2nd. The shares were sold at an average price of $604.07, for a total transaction of $271,831.50. Following the transaction, the director now directly owns 6,929 shares of the company’s stock, valued at $4,185,601.03. This represents a 6.10 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last three months, insiders sold 8,711 shares of company stock valued at $5,631,561. Company insiders own 5.70% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of research firms recently issued reports on AXON. JMP Securities reiterated an “outperform” rating on shares of Axon Enterprise in a research note on Tuesday, February 4th. Craig Hallum lowered shares of Axon Enterprise from a “buy” rating to a “hold” rating and set a $625.00 target price on the stock. in a research note on Thursday, February 20th. Northcoast Research lowered shares of Axon Enterprise from a “buy” rating to a “neutral” rating in a research note on Wednesday, February 19th. Morgan Stanley upgraded shares of Axon Enterprise from an “equal weight” rating to an “overweight” rating and raised their price target for the stock from $500.00 to $700.00 in a research report on Tuesday, December 3rd. Finally, Northland Securities raised their price target on shares of Axon Enterprise from $365.00 to $550.00 and gave the stock an “outperform” rating in a research report on Monday, November 11th. Three equities research analysts have rated the stock with a hold rating and thirteen have issued a buy rating to the company’s stock. Based on data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and a consensus target price of $587.38.

Check Out Our Latest Research Report on AXON

Axon Enterprise Price Performance

NASDAQ:AXON opened at $525.63 on Friday. The company has a 50-day moving average of $611.62 and a 200-day moving average of $522.09. The company has a market capitalization of $40.08 billion, a price-to-earnings ratio of 135.82, a PEG ratio of 5.17 and a beta of 1.05. Axon Enterprise, Inc. has a 52 week low of $273.52 and a 52 week high of $715.99. The company has a debt-to-equity ratio of 0.32, a quick ratio of 2.63 and a current ratio of 2.96.

About Axon Enterprise

(Free Report)

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.

Read More

Want to see what other hedge funds are holding AXON? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Axon Enterprise, Inc. (NASDAQ:AXONFree Report).

Institutional Ownership by Quarter for Axon Enterprise (NASDAQ:AXON)

Receive News & Ratings for Axon Enterprise Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Axon Enterprise and related companies with MarketBeat.com's FREE daily email newsletter.